IRB Review of Phase I Research: Balancing Ethics and Efficiency
Phase I research demands careful IRB oversight, balancing participant safety with timely reviews. Proactive strategies can help address its unique challenges.
Research Operations
3 Must-Haves to Deploy Remote Clinical Trials
This blog covers three must-have decentralized trial tools to efficiently and compliantly implement remote modalities at your organization.
Understanding eSource, ePRO, and EDC
eSource, ePRO, and EDC each play distinct roles in clinical trials, enhancing data consistency, participant experience, and overall study efficiency through technology integration.
Beginner’s Guide to Minimal Risk Research
When an institutional review board (IRB) determines research is “minimal risk” (as defined in Department of Health and Human Services
Understanding Medical Science Liaisons and Clinical Liaisons
Research organizations utilize a variety of medical professionals to conduct successful clinical trials. Two of those positions are a medical
Maintaining a Robust Clinical Trial Pipeline
The clinical research landscape is likely forever altered by the COVID-19 pandemic, especially regarding trial continuity and the potential for
4 Key Integrations for Your Clinical Trial Management System
In this blog are some key CTMS integrations — using systems your institution has likely implemented — your team can use to streamline research operations.
Why it is Critical to Have and Enforce a Data Strategy?
The Call to Action Data is the most important asset for a pharmaceutical or biotechnology company to produce during clinical
Optimizing a Clinical Development Program to Improve ROI
Clinical development proceeds in phases, and each phase contains a set of clinical trials. These trials, including their sample size
IRB Review of Social Media Recruitment and Retention Programs
Social media can be a valuable tool for researchers to connect with and recruit potential clinical trial participants. However, US regulations
The Value of Early Engagement with Your IRB
It’s no secret that in clinical research, everything moves at a quick pace – and that doesn’t stop when working